Beutel, Goodman & Co’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.31M Sell
36,671
-1,475
-4% -$344K 0.07% 75
2026
Q1
$9.32M Sell
38,146
-3,310
-8% -$771K 0.06% 73
2025
Q4
$8.58M Sell
41,456
-575
-1% -$114K 0.05% 69
2025
Q3
$7.79M Sell
42,031
-750
-2% -$128K 0.05% 71
2025
Q2
$6.53M Sell
42,781
-2,495
-6% -$384K 0.04% 71
2025
Q1
$7.51M Buy
+45,276
New +$7.08M 0.04% 70
2018
Q4
Sell
-240,450
Closed -$25.7M 65
2018
Q3
$25.7M Sell
240,450
-3,839
-2% -$510K 0.19% 51
2018
Q2
$22.6M Buy
244,289
+4,656
+2% +$581K 0.17% 49
2018
Q1
$24.3M Sell
239,633
-10,604
-4% -$1.43M 0.18% 46
2017
Q4
$27.9M Buy
+250,237
New +$34.9M 0.19% 47

Other funds holding JNJ

Beutel, Goodman & Co's JNJ Position: Q2 2026 in Review

Beutel, Goodman & Co reduced its Johnson & Johnson (JNJ) stake by 3.9% in Q2 2026, selling an estimated $344K and leaving 36,671 shares worth $9.31M. The position accounts for 0.07% of the portfolio, ranked #75.

Beutel, Goodman & Co first reported a position in JNJ in Q4 2017 and has held it in 10 quarters since. The position peaked at $27.9M in Q4 2017. 4,676 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Beutel, Goodman & Co held 36,671 shares of Johnson & Johnson worth $9.31M as of Q2 2026.
  • Beutel, Goodman & Co sold 1,475 Johnson & Johnson shares in Q2 2026, an estimated $344K.
  • Johnson & Johnson made up 0.07% of Beutel, Goodman & Co's portfolio in Q2 2026, its #75 holding.
  • Beutel, Goodman & Co first reported a position in Johnson & Johnson in Q4 2017 and has held it in 10 quarters since.
  • Beutel, Goodman & Co's Johnson & Johnson position peaked at $27.9M in Q4 2017.
  • 4,676 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Beutel, Goodman & Co's 13F filing for Q2 2026, filed 12 Aug 2026.